Curcumol Overcomes TRAIL Resistance of Non-Small Cell Lung Cancer by Targeting NRH:Quinone Oxidoreductase 2 (NQO2).
Resistance to tumor-necrosis-factor-related apoptosis-inducing ligand (TRAIL) of cancer cell remains a key obstacle for clinical cancer therapies. To overcome TRAIL resistance, this study identifies curcumol as a novel safe sensitizer from a food-source compound library, which exhibits synergistic lethal effects in combination with TRAIL on non-small cell lung cancer (NSCLC). SILAC-based cellular thermal shift profiling identifies NRH:quinone oxidoreductase 2 (NQO2) as the key target of curcumol. Mechanistically, curcumol directly targets NQO2 to cause reactive oxygen species (ROS) generation, which triggers endoplasmic reticulum (ER) stress-C/EBP homologous protein (CHOP) death receptor (DR5) signaling, sensitizing NSCLC cell to TRAIL-induced apoptosis. Molecular docking analysis and surface plasmon resonance assay demonstrate that Phe178 in NQO2 is a critical site for curcumol binding. Mutation of Phe178 completely abolishes the function of NQO2 and augments the TRAIL sensitization. This study characterizes the functional role of NQO2 in TRAIL resistance and the sensitizing function of curcumol by directly targeting NQO2, highlighting the potential of using curcumol as an NQO2 inhibitor for clinical treatment of TRAIL-resistant cancers.
['Zhang|Jing|J|', 'Zhou|Ye|Y|', 'Li|Nan|N|', 'Liu|Wan-Ting|WT|', 'Liang|Jun-Ze|JZ|', 'Sun|Yue|Y|', 'Zhang|Wei-Xia|WX|', 'Fang|Run-Dong|RD|', 'Huang|Sheng-Ling|SL|', 'Sun|Zheng-Hua|ZH|', 'Wang|Yang|Y|https://orcid.org/0000-0001-6440-0204', 'He|Qing-Yu|QY|https://orcid.org/0000-0003-0503-9492']
curcumol quinone oxidoreductase 2 cellular thermal shift assay profiling non‐small cell lung cancer tumor‐necrosis‐factor‐related apoptosis‐inducing ligand resistance